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Abstract
Background: Maori, the indigenous people of New Zealand, who present to hospital after intentionally harming
themselves, do so at a higher rate than non-Maori. There have been no previous treatment trials in Maori who self
harm and previous reviews of interventions in other populations have been inconclusive as existing trials have
been under powered and done on unrepresentative populations. These reviews have however indicated that
problem solving therapy and sending regular postcards after the self harm attempt may be an effective treatment.
There is also a small literature on sense of belonging in self harm and the importance of culture. This protocol
describes a pragmatic trial of a package of measures which include problem solving therapy, postcards, patient
support, cultural assessment, improved access to primary care and a risk management strategy in Maori who
present to hospital after self harm using a novel design.
Methods: We propose to use a double consent Zelen design where participants are randomised prior to giving
consent to enrol a representative cohort of patients. The main outcome will be the number of Maori scoring
below nine on the Beck Hopelessness Scale. Secondary outcomes will be hospital repetition at one year; self
reported self harm; anxiety; depression; quality of life; social function; and hospital use at three months and
one year.
Discussion: A strength of the study is that it is a pragmatic trial which aims to recruit Maori using a Maori clinical
team and protocol. It does not exclude people if English is not their first language. A potential limitation is the
analysis of the results which is complex and may underestimate any effect if a large number of people refuse their
consent in the group randomised to problem solving therapy as they will effectively cross over to the treatment as
usual group. This study is the first randomised control trial to explicitly use cultural assessment and management.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12609000952246
Background
Maori are the indigenous people of New Zealand and
make up about 15% of the population. Māori have a one
year prevalence rate of “suicide attempts” that is three
times higher than non-Mäori (0.9% twelve month preva-
lence compared to 0.3% in non-Maori) [1] and have a
suicide rate that is about 30% higher than non-Maori
(13.3/100,000 compared to 10.6/100,000)[2]. The chal-
lenge is to provide effective treatment for Maori who
p r e s e n tt oh o s p i t a lw i t hs e l fh a r mt h a ti sc u l t u r a l l y
acceptable and meets the obligations of the Treaty of
Waitangi.
There are over 5000 hospitalisations for self harm
each year in New Zealand and a history of self harm is
the most powerful predictor of subsequent suicide with
about 1% of people going on to kill themselves in the
year after a self harm attempt [3]. In the most recently
updated Cochrane review of treatments for self harm no
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single intervention in reducing repetition rates of self
harm [4]. Subsequent to this review several large trials
have reported their results with mixed findings. We pro-
pose a novel approach to this problem by providing a
“package of care” delivered by specialised self harm
teams. The package is an integrated combination of six
interventions which are likely to make a difference to
outcomes after self harm and address a variety of risk
factors. This “package of interventions” has the potential
to add to worldwide knowledge about the efficacy of
interventions for self harm. The rationale for the inter-
ventions we have chosen to offer as part of Te Ira Tan-
gata are described below.
Firstly there are postcards sent to patients after the
episode of self harm. In 2005 Greg Carter developed an
intervention in which a series of eight “postcards” were
sent in sealed envelopes over one year after discharge to
patients who had presented at emergency departments
for self-poisoning [5]. At one year follow-up patients in
the intervention group had half the number of readmis-
sions than the control group (101 vs 192) although the
proportion of people re-presenting in each group was
not significantly different. In a more recent trial in
Christchurch by Annette Beautrais [6] of a similar inter-
vention there was no difference in outcomes once the
history of self harm had been taken into account in
both groups. However the study sample was small and
included people presenting to a crisis team with suicidal
ideas as well as presentations with self harm to the
emergency department.
Secondly there is Problem-solving therapy (PST)
which is a brief focused psychological treatment that has
been shown to be significantly more effective than con-
trol conditions with regard to improvement in depres-
sion, hopelessness and problems in patients who have
attempted suicide [7]. Evidence that problem solving
therapy is effective in reducing repetition rates is less
conclusive, although promising trends have been
reported [8]. There is general agreement that problem
solving therapy is a cost-effective, brief intervention that
has the potential to be a feasible and effective addition
to existing services [7].
N e x ti st h ei s s u eo ft h eh i g hm o r t a l i t yr a t ef r o mn o n
suicide causes after self harm. About 50% of the prema-
ture mortality after self harm is due to non suicide
deaths [9] and the overall rate of death may reach 15%
five years after the index episode of self harm [10]. This
suggests that treating self harm as purely a mental
health problem will not address a key outcome.
A related problem is the issue of patients not getting
the treatment that clinicians say they should receive in
the management plans made in the emergency depart-
ment. There are a variety of reasons for this including
patients’ resistance to attend appointments, referrals not
being made in a timely fashion or contact details
recorded in the emergency department being incorrect.
T h e r ei ss o m ee v i d e n c et h a tm o r ei n t e n s i v eo u t r e a c h
after self harm results in better attendance in out-
patients although it is unclear whether this decreases
the repetition rate [8].
A difficult and controversial area is the management
of risk for the individual and the team. Traditionally risk
assessment in mental health, especially in the area of
suicide prevention, has focused on prediction, using risk
factors associated with the patient, so that patients are
said to be at low, medium and high risk. The difficulty
with this is that there is no evidence that clinicians can
predict who will commit suicide and most people who
kill themselves are low risk and most people who are
high risk don’t kill themselves [11]. This suggests that
using risk assessment to predict who will kill themselves
is flawed and that a better system is needed.
Lastly a neglected component of assessment in mental
health, with the notable exception of ‘cultural services’,
is the clinical assessment of identity and belonging in
people who self harm. This is particularly surprising
given that firstly having a damaged autobiographical
memory [12] and a poor sense of belonging [13] are
relatively common in people who self harm and sec-
ondly that there is a tradition within psychiatry that sees
development of a strong sense of identity as desirable
for good mental health. Kaupapa Maori services have of
course seen the development of a secure identity as an
essential part of their task. Also those who receive pro-
blem solving will be prompted to consider “not belong-
ing” as a potential problem to be addressed. Previous
research has shown that having a secure cultural identity
is less common in Māori who self harm compared to a
control population [14]. The proposed study follows on
from this research and is an attempt to address issues of
cultural identity in Māori who self harm to see if this
protects them from further self harm and improves
other outcomes.
We propose to include each of these components in a
package of care delivered to individuals after they pre-
sent with self harm. By combining them together we
aim to replicate the package of interventions that a clini-
cal “self harm team” could reasonably deliver and to test
the idea that the effect of the package is more than the
sum of the individual parts. The parts of the package
will be sending postcards over a year; the offer of brief
problem solving therapy; patient support which will be a
mainly telephone based system of case management to
“stop people falling through the cracks” after their pre-
sentation to hospital; vouchers that will allow patients to
access their GP’s for free with an emphasis on physical
health checks and ensuring registration with a GP; a
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able risk factors in the patient and the self harm team
based on the principles successfully used in managing
risk in aviation; and a cultural assessment focused on
sense of belonging.
The package of care that will be delivered as part of
Te Ira Tangata will meet the three principles that
underpin good clinical practice from a Maori perspec-
tive [15]. These are:
I. The principles of indigeneity which recognises
indigenous peoples rights to exercise a degree of
autonomy. The face to face problem solving in Te
Ira Tangata will be developed by Maori to ensure
that the “rituals of encounter”, the delivery and con-
tent are acceptable to Maori.
II. The principle of clinical expertise which acknowl-
edges the rights of Mäori to get the best treatment
available. The package of care delivered in this study
combines the evidence based treatments which are
most likely to improve outcomes for Mäori who pre-
sent to hospital with self harm.
III. The principle of cultural competence which
focuses on clinicians ability to be competent to work
in their own and others cultures. In Te Ira Tangata
the research clinicians are Maori seeing Maori
patients supported by Mäori cultural workers.
This study begins to address the need for an evidence
base for the effectiveness of Maori specific services that
is clearly articulated by Tapsell in his description of
similar services in a forensic psychiatry setting [16].
Why use a Zelen design?
Systematic reviews have identified small randomised
trials of unrepresentative patients as a problem in this
area. This study uses a double consent Zelen randomisa-
tion design [17]. In this design individuals are rando-
mised before they give consent. The reason for choosing
this design, rather than the standard randomised con-
trolled trial design, is that in a standard randomised
controlled trial clients are required to understand com-
plex concepts such as randomisation and clinical equi-
poise before giving consent. Such an approach is likely
to be inappropriate for people in crisis, in an emergency
room, and who are often physically unwell following a
self harm episode. Consequently the use of a Zelen
design has the potential to improve recruitment rates as
the conversation with eligible patients is simpler. Also
the people who consent to randomisation in conven-
tional trials may well be unrepresentative of the people
who present following self harm [8]. More importantly,
if people are offered the possibility of receiving pro-
blem-solving therapy but then find that they have been
randomised to receive treatment as usual only, this may
result in higher rates of non-compliance in the control
group as well as the possibility of “resentful demoralisa-
tion” [18], resulting in higher drop-out rates from the
control group or reporting of lower scores on outcome
measures.
The aim of the study is to see whether, in Māori who
present to hospital after self harm, a culturally informed
package of care, Te Ira Tangata, leads to better out-
comes than treatment as usual alone. Specifically we
have the following hypotheses:
1. A culturally informed treatment is more effective
than treatment as usual in reducing the proportion
of Maori who score below nine on the Beck Hope-
lessness Scale at one year. This is the primary
outcome.
2. A culturally informed treatment is more effective
than treatment as usual in reducing hospital repre-
sentations with self harm, self-reported repetition of
self-harm, hopelessness, depression, anxiety and
health service use after three months and one year.
3. Māori who receive Te Ira Tangata are more likely
to engage with support than those who receive cur-
rent usual treatment in New Zealand.
4. The package of care plus treatment as usual will
improve quality of life and function at three months
and one year compared to treatment as usual.
5. The package of care will be more cost effective
than treatment as usual.
Methods
Design
We will use a Zelen randomised controlled design to
compare the package of care plus treatment as usual to
treatment as usual in Maori who presented to hospital
with self harm.
Settings
The study will be conducted in four hospitals in three
District Health Boards (DHB) in New Zealand - Waite-
mata DHB (North Shore Hospital and Waitakere Hospi-
tal), Counties Manukau DHB (Middlemore Hospital)
and Northland DHB (Whangarei Hospital). Waitemata
District Health Board provides health services for a
population of about 525,000 people in urban north and
west Auckland and a rural area north of the city with
about 17% of its population living in the most deprived
areas; Counties Manukau provides health care for
470,000 people in the South of Auckland and serves a
population that is relatively young with a high propor-
tion of Maori and recent immigrants and about a third
of the population living in areas that are very deprived
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lation-profile.htm); Northland District Health Board
serves a mainly rural area of about 150,000 characterised
by a large Maori population, widely dispersed rural
communities and a disproportionately high level of
socio-economic deprivation.
Participants
All adult Māori patients (that is those who are not still
at secondary school) who present to the emergency
departments of North Shore, Waitakere, Middlemore
a n dN o r t h l a n dh o s p i t a l sw h oa r ea b l et og i v ei n f o r m e d
consent will be eligible for the study. Māori patients will
be approached by a research team member while in hos-
pital or within 48 hours of discharge. Patients who
require an interpreter will be included in the study. Self-
harm is defined as intentional self-poisoning or self-
injury, irrespective of motivation. Self-poisoning includes
the intentional ingestion of more than the prescribed
amount of any drug, whether or not there is evidence
that the act was intended to result in death. This also
includes poisoning with non-ingestible substances (for
example pesticides or carpet cleaner), overdoses of
‘recreational drugs’ and severe alcohol intoxication
where the clinical staff consider such cases to be an act
of intentional self-harm. Self-injury was defined as any
injury that has been intentionally self-inflicted [19]. We
will assess the degree of suicidal intent by using a modi-
fied self report version of the Beck Suicide Intent Scale
which we will use in the analysis to assess the impact
suicidal intent on outcomes.
People will be excluded if they are aged under 17; are
still at school; are unable to give informed consent to be
part of the study, that is, if they are too mentally unwell
(for example they are psychotic or hypomanic); if they
are too physically unwell (for example, they are in a
coma or with lowered level of consciousness); or if they
are severely cognitively impaired.
Recruitment
Following a psychosocial assessment by a non-study
mental health clinician, patients will be handed a card
by non-study clinician which informs them that they
will be approached to participate in a study about what
happens after self-harm (Additional file 1). If patients do
not want to be contacted they will be asked to inform
one of the non-study staff. Eligibility for the study will
be assessed by a research therapist reviewing the notes.
Eligible patients will be randomised and then
approached by the research clinician to explain the
study and to request consent to participate.
The maximum delay between the psychosocial assess-
ment and the attempt to obtain consent is four days to
allow for weekends and public holidays when research
staff are not available. In practice we aim to approach
potential participants within 24 hours of their presenta-
tion to the hospital. The approach will occur either
within the Emergency Department, in hospital if the
person is admitted, or where necessary, by telephone
after the patient is discharged. An interpreter will be
made available to any person who requests one.
Randomisation and blinding
As this is a Zelen trial randomisation will be prior to
obtaining consent. All eligible participants are allocated
randomly to the intervention or usual care groups using
a central computerised randomisation system at the
Clinical Trials Research Unit (http://www.ctru.auckland.
ac.nz). Stratified minimisation randomisation will be
used to ensure a balance in key prognostic factors
between the study groups: site (Waitemata DHB, Coun-
ties Manukau DHB, Northland DHB), history of self-
harm (none, repeater), and method of self-harm (over-
dose, self injury, both). The assessors will be blind to
the intervention group at the three and twelve months
follow up assessments.
The intervention
The content of the intervention meets the aims of Pai-
heretia as described by Durie [20]. That is we aim to
help the client develop a secure identity, we pay atten-
tion to their relationships which may need healing and
the problem solving encourages reciprocity with the
wider environment. As well as the content we aim to
make the process of therapy explicitly incorporate
Maori cultural beliefs and values which we have chosen
to describe using the powhiri model described below.
The powhiri model
Each iwi (tribe) throughout Aotearoa (New Zealand)
practises their own variation of kawa (protocol) on their
home marae (tribal meeting places). With this research
t h e r ew i l lb e1 3 2M āori presenting to three DHB
regions (Northland, Waitemata and Counties Manukau)
from a number of iwi, not necessarily mana whenua
(people of that region). Therefore, a powhiri (welcoming
ceremony) process is the most appropriate method of
engagement when Māori researchers and Māori partici-
pants come together.
Before the powhiri, the kawa is conveyed to the visi-
tors so that they understand what is expected of them.
Thus the kawa determines how both the hosts and visi-
tors interact within the sacred boundaries of the marae.
For the purposes of this research the marae may equate
to the clinical setting, hauora, Māori organisation or
local marae.
The conveying of the kawa for Te Ira Tangata is the
first level of engagement and can be indicated through
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and the information sheets.
Taki/Wero - Challenge
Before the powhiri can begin, the tangata whenua
(researchers) must challenge the manuhiri (visitors -
participants) to make sure of their intentions and ensure
they have come in peace. If their intentions are friendly,
the participants will accept the rautapu (a leaf or carved
effigy) a symbolic offering of peace. Once the challenge
is completed, the warriors will guide you on to the
sacred ground of the marae, while the karanga or call of
the women of the tribe welcomes you.
Te Ira Tangata will offer the rautapu in the form of a
consent form if the participant accepts the peace offer-
ing they will sign and return the form to participate in
the study.
Karanga - Call
Karanga refers to the ceremonial call of welcome. The
start of the karanga indicates to a visitor that they are
free to approach their hosts across the marae atea
(sacred space directly in front of the meeting house).
The call also clears a spiritual pathway for the ancestors
of both visitor and host to meet and partake in the cere-
monial uniqueness of the powhiri. The call acknowl-
edges the ancestral spirits of the visitors before them.
The karanga acknowledges who you are and why you
have come, and invite you to stop and shed tears for
those who have passed on.
This is the beginning of the ‘Patient Support’ process
within Te Ira Tangata. Where the tangata whenua
(research clinician and administrator) have already
reviewed clinical notes, checked any management plans
and whether they need updating, offered GP voucher,
performed risk assessments, referrals in operations and
any change of circumstances.
Karakia - Blessing
Karakia are prayers that acknowledge a spiritual pre-
sence. When applied to a specific realm or occasion,
each karakia would identify and acknowledge gods, demi
gods and lesser spiritual deities so that nothing unto-
ward should befall those involved. During a powhiri, the
tangata whenua (people of the land) and manuhiri (visi-
tors) often participate in karakia. This unites everyone
present in body and spirit, and blesses the occasion.
Once the karakia is completed, things begin to lighten
up. It’st i m ef o rt h em i h ia n dw h a i k o r e r o ,w h i c h
amongst other things, talk about issues of the day and
the reason for gathering.
Karakia is karakia in Te Ira Tangata and will be per-
formed in appropriate sense for both the research clini-
cian and the participant.
Mihi/Whaikorero - Greetings
T h en e x tp h a s eo ft h ep o w h i r ii n v o l v e st h em i h ia n d
whaikorero, formal greetings exchanged between host
and visitor. This phase is a very formal part of the
powhiri. The hosts consider each visitor as sacred,
according them all the rights that their position
demands. As a visitor, you are expected to act in a dig-
nified manner, for Māori accept your physical presence
as representing all your ancestors. It is considered rude
to show disinterest during these proceedings or talk
over someone delivering their mihi. The exchange
between research clinician and participant during PST
forms the Mihi/Whaikorero.
There is a saying ‘Ko te whaikorero, te kai a te Ranga-
tira - Oratory is the food of Chiefs’. Today, as it was in
former times, the arts of whaikorero and mihi are
greatly revered. A good speaker will have both visitors
and hosts in the palm of his hand, laughing or crying. A
good research clinician will also be able to represent
these skills during Te Ira Tangata.
Problem solving therapy has five steps including pro-
blem orientation, problem identification, generating
solutions, making an action plan and reviewing the pro-
gress. As part of the problem orientation there will be
an acknowledgement of:
I. the land
II. the dead
III. the reason for the gathering
IV. the wharenui (big house)
V. the people present.
This can form the cultural assessment process investi-
gating a person’s cultural identity profile. Using these
outcomes a person’s identity profile and sense of
belonging will inform one of the ‘problems’ to be solved
within the therapy.
Waiata - Song
The singing of waiata or song usually follows each mihi
and whaikorero (formal greetings exchanged between
host and visitor). Today waiata are sung in many lan-
guages and for many different reasons. Visitors that sing
of their homeland or in their native tongue are said to
bestow their hosts with the voice and sound of their
ancestors. This is considered a great gift and honour.
At the end of the first PST session there is an oppor-
tunity for the participant to identify problems (list),
chose one problem to work on, define the problem and
g e n e r a t eas o l u t i o n .W h e nt h e yl e a v et h es e s s i o nt h e y
will be able to work on this and bring back progress to
the next session.
Koha - Gift
Koha is the traditional act of gifting. In the powhiri
(welcoming ceremony) the presentation of koha follows
directly after the last speaker has finished their mihi
(formal greetings) and waiata (song). The gifting of koha
is a very dignified act.
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be given on the completion of the rating scales at base-
line, 3 month follow up and 12 month follow up. This is
a mark of reciprocity from the study to the participant.
Hongi - Coming together
The next stage of the powhiri, the hongi (pressing of
noses), the ha or breath of life is exchanged and inter-
mingled. Through the exchange of this physical greeting,
you are no longer considered manuhiri (visitor) but
rather tangata whenua, one of the people of the land.
The hongi is also a sign of life symbolising the action of
Tane’s breath of life to humans. By this action the life
force is permanently established and the spiritual and
physical bodies become a living entity.
This symbolises the end of the therapy, participants
have had their mauri (life force) restored, rejuvenated
and supported.
Hakari - Feast
Hakari is the act of ritual feasting that traditionally
applied to the eating of cooked food. Symbolically, the
hakari recognises the transition from the spiritual realm
of the powhiri back into the physical world where food
is shared.
At the completion of patient support and each of the
PST sessions participants will be offered food and drink.
Poroporoaki - Farewell
Poroporoaki, or speeches of farewell, are reserved for
the final part of the powhiri but are by no means the
least important part of the process. The poroporoaki is
the act of farewell and the return of mana (esteem and
authority) to the host people. This is operationalised by
t h ew r i t i n ga n ds h a r i n go faf i n a ld i s c h a r g el e t t e rt o
other people involved in the participants care.
Intervention group
Māori randomised to the experimental group (Te Ira
Tangata) who give their consent will be offered the fol-
lowing by the self harm team:
1 .P a t i e n ts u p p o r tf o ru pt ot w ow e e k s .T h i sw i l l
consist of one or two face-to-face or telephone ses-
sions depending on patient preference and feasibility
over the two week period following the participant’s
discharge from hospital. These sessions will involve
obtaining the discharge plan developed by the asses-
sing clinicians, checking that the patient understands
it, identifying potential barriers to implementation of
the plan and assisting the patient to follow through
with the plan. In other words, the primary aim of
patient support will be to ensure patients do not
“fall through the cracks”. The research clinicians will
be expected to liaise with the mental health crisis
and community mental health teams; alcohol and
drug services; primary care and non health services.
Each patient support session will include a risk
assessment asking about thoughts and plans for self
harm. If a patient is identified as being at risk of self
harm the risk management protocol will be followed.
2. Postcard contact for one year. Eight postcards will
be sent in sealed envelopes in months 1,2,3,4,6,8,10
and 12 after the index episode. The cards will con-
tain a short message stating that we hope things are
going well and inviting them to write us a note if
they wish to (Additional file 2). Each envelope will
contain a return stamped addressed envelope.
3. Problem solving therapy. This will consist of four
to six sessions in the four weeks after the partici-
pant’s index presentation to hospital for self harm.
Research clinicians will assess the participant’s elig-
ibility for brief problem solving therapy prior to and
at the initial patient support session. Patients may be
ineligible for brief PST if they are already receiving
psychotherapy (for example if they are receiving Dia-
lectical Behaviour Therapy), if brief PST would con-
tradict their management plan, if they live or are
moving out of area, if they are in prison or if there
is a risk of harm to the research clinician. The pro-
blem solving therapy we will use in the treatment
package will be conducted with individual patients
and is based on the model originally defined by
D’Zurilla and Goldfried [21]. PST sessions will aim
to teach the person to recognise and identify current
problems and will provide them with a structured
approach to problem solving. A clinician manual
and a participant workbook will be used by the
research team to guide the structure of PST sessions.
Sessions will be audiotaped.
4. Improved access to primary care. We will encou-
rage participants to attend their GP for a physical
health check paying particular attention to cardio-
vascular risk factors especially alcohol and smoking.
We will use GP vouchers to facilitate these visits.
5. A risk management strategy. The teams will also
pilot a risk management strategy around the man-
agement of suicidal patients. This will consist of a
checklist for patient support to ensure that key tasks
are completed and questions asked. Secondly the
research team will meet once a week to discuss
adverse events defined as repeat episodes of self
harm, hospital re presentation for any reason and
suicides. A record will be kept of these discussions,
including any changes to process as a result of these
discussions, and circulated to the team in the form
of a “risk bulletin”. The research team will also
receive training in crew resource management.
6. Cultural assessment. We have two aims here, the
first is to increase the number of people who receive
cultural services after self harm. From our previous
study we found that the input of Maori services after
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complete a cultural assessment on everyone paying
particular attention to the sense of belonging and feel-
ings around ethnicity. Problems with sense of belong-
ing will be included in the problem solving checklist
for patients.
Control group
Māori patients randomised to the control group who give
their consent will receive treatment as usual and will be
asked to complete a consent form and questionnaires at
baseline, and questionnaires and telephone interviews at
three months and one year. Treatment as usual following
self harm varies and may involve referrals to multi-disci-
plinary teams for psychiatric or psychological intervention,
referrals to crisis teams and/or recommendations for
engagement with community alcohol and drug treatment
centres. The discharge plan may include referrals to more
than one health care provider, or may consist solely of
referral back to the patient’s General Practitioner.
Treatment as usual assessment Treatment as usual for
all participants will be assessed by self report using a writ-
ten questionnaire and telephone interview by a research
assistant blind to treatment allocation; a review of DHB
records; and by using the National minimum dataset from
the Ministry of Health Information Directory to record
hospital contacts and contact with mental health services.
Outcome measures (Table 1)
Intervention study The primary outcome measure is
the proportion of subjects who score below nine on the
Beck Hopelessness Scale after one year (see sample size
section for explanation).
Secondary outcomes are:
1. The proportion of subjects who repeat self harm
by presenting to hospital at three months and one
year after their index attempt.
2. Self reported repetition of self harm at three
months and one year, assessed with a telephone
questionnaire and a written questionnaire
3. Hopelessness measured by the Beck Hopelessness
Scale at baseline, three months and one year
4. Anxiety and depression measured by the Hospital
Anxiety and Depression Scale at baseline, three
months and one year
Table 1 Outcome measures
Outcome
measure
Description Explanation Administered
Primary
Hopelessness Beck Hopelessness Scale (BHS)[22] Scores below 9 on the BHS. Best predictor of subsequent self harm.
Scores on a range of 0 to 20 with higher scores indicating greater
hopelessness.
Entry, three and
twelve months
Secondary
Hospital
repetition of
self harm
Data on hospital contacts from participating DHB’s and the New
Zealand Health Information Service National Minimum Dataset
Three and
twelve months
Depression and
anxiety
Hospital Anxiety and Depression Scale
(HADS)[23]
Self report scale. Scores of 10 and above on the anxiety and
depression sub scales indicate clinically significant symptoms.
Baseline, three
and twelve
months.
Health status EQ-5D [24] A generic health-related quality of life index that can be related to
costs.
Baseline, three
and twelve
months.
Self report
repetition of
self-harm
Self report assessed by telephone interviewer blind to allocation Three and
twelve months
Social
functioning
SF-36 [25] A generic measure of functional health and well being Baseline, three
and twelve
months
Sense of
belonging
Sense of belonging instrument (SOBI)
[26]
Self report scale on sense of belonging to a community and ethnicity Baseline, three
and twelve
months
Cultural identity Cultural identity profile [27] Produces four indicators of cultural identity, a secure, positive, notional
or compromised identity
Baseline, three
and twelve
months
Seriousness of
suicide attempt
Self rated objective part of the Beck
Suicide Intent Scale (BSIS)[28]
Self report scale indicating the degree of suicidal intent of the self
harm episode
Baseline
Costs following
index attempt
Health service use, costs of attending
care, cost of medication and time off
work
Self report assessed by telephone interviewer blind to allocation Three and
twelve months
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Page 7 of 115. Quality of life as measured by the EQ-5D (http://
www.euroqol.org/) and the SF36 at baseline, three
months and one year
6. Overall mortality (that is suicide deaths plus other
causes of death) and suicide deaths at three months,
one year, five years and ten years
7. Health service use at three months, one year, five
years and ten years, assessed by a telephone ques-
tionnaire and interrogation of DHB and Ministry Of
Health Information Directorate records
Outcome measures will be collected in several differ-
ent ways.
Self report or self rating Ratings scales will be by self
rating. Self report will be to a researcher blind to the
treatment allocation by a semi structured telephone
interview which asks about repetition, health service use
and economic measures (see attached copy of
questionnaire).
DHB records we will inspect these for episodes of repe-
tition and health service use.
Ministry Of Health Information Directorate records
we will inspect these for health service use (both general
and mental health), repetition and for mortality data. (It
is necessary to look at national data on these measures
as we found in our previous trial that at least 50% of
people who self harm change address over twelve
months often outside the DHB where they presented).
Self report by structured interview
Information for the economic analysis and self report of
repetition will be gathered by telephone interview at
three months and one year after the index attempt (Addi-
tional file 3). Telephone interviewers will be blind to the
allocation of subjects. Blinding will be tested by asking
the interviewers to nominate which group the subject
was enrolled in. The economic analysis will also use a
brief measure of quality of life the EQ-5D and inter-
viewers will ask about health service use; costs associated
with this; time off work; time off work for family to care
for the participant; changes in benefit; changes in occu-
pation; and drug use and cost. Participants will have the
option of completing these measures in a face to face
interview if, for example, they do not have a phone.
Process evaluation
A process evaluation will explore the implementation,
receipt and context of the intervention with a view to
helping understand the results in accordance with the
Medical Research Council’sg u i d e l i n e s[ 2 9 ]o na s s e s s i n g
complex interventions. This will describe the processes
in the intervention and control groups, provide informa-
tion about the contexts in which the treatments are
delivered and supply information about the experience
of being part of the trial. The process evaluation is
described in Table 2 below. The self-harm teams will
also receive weekly supervision, the main themes of
which we will incorporate into the process evaluation.
Process evaluation analysis
Numerical data will be entered into the Clinical Trials
Research Unit web based data entry system specifically
designed for this study. Information from the examina-
tion of patient notes and audiotapes will be used to
assess the adherence of therapists to the manual in a
10% random sample of those who completed problem
solving therapy. Data from structured interviews and
focus groups will be analysed for emergent themes using
NVIVO.
Table 2 Process evaluation in Te Ira Tangata
Data collection method Data collected
Programme documentation and observation (to assess
fidelity, dose and reach)
Number of sessions of patient support
Number of PST sessions
Completion of PST
Audiotaping of PST sessions
Examination of written client PST research records
Number of clients where sense of belonging addressed in PST
Use of GP voucher
Number of postcards sent
Summary of discussions around adverse events
Proportion of clients who received the interventions in each centre
Proportion of clients not contactable after presentation to hospital
Structured interviews (to assess barriers, facilitators
and suggestions for improvement)
Interview research clinicians re barriers and facilitators to the interventions plus suggestions
for improvement
Interview purposive sample of patients re what helped and what did not help plus
suggestions for improvement
Twelve month telephone interview of all patients what helped and what did not help
Interview GP’s who saw clients through GP voucher to assess their perception of the
intervention and suggestions for improvement
Interview focus group of staff in mental health and cultural services re barriers and
facilitators to interventions plus suggestions for improvement
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Power analysis
We know from the previous trial that approximately 310
Māori present with self harm each year to the general
hospitals in Waitemata, Counties Manukau and North-
land DHB’s [30]. Of these 70% or 217 would have been
eligible for this study. Assuming that we recruit partici-
pants at the same rate as the previous trial, that is 50%
of eligible people, we would be able to recruit about 105
people a year from these DHB’s, (or about 150 over
eighteen months).
Traditionally the main outcome measure in self harm
intervention research has been the proportion of people
repeating after one year which is generally around 18%
(29). However there are two problems here one of
which is particularly relevant for indigenous people.
Firstly to significantly reduce this by a third to 12%
would need nearly 600 people in each arm of a trial
(assuming a power of 80% with a significance level of
0.05). This is particularly problematic in trials involving
indigenous people who are less numerous than the
majority population. In New Zealand there are about
1000 episodes of self harm involving Māori each year
which represents about 840 people. Assuming similar
rates of eligibility and recruitment as in the earlier trial
this means that the maximum number of Māori who
could be enrolled in a treatment trial powered on a sig-
nificant reduction in the repetition rate is about 300
people a year. In other words a trial would have to
involve every DHB in the country and recruit people for
four years. We suspect that the chances of funding any
such trial are slim. The second problem with repetition
rates is that although they are clearly a key considera-
tion they are not important for the four out of five peo-
ple who do not repeat. Other outcome measures such
as measures of distress, quality of life and cultural iden-
tity are also significant. For these reasons we have
decided that the main outcome we are interested in
after one year is the proportion of people scoring below
9 on the Beck Hopelessness Scale. We have chosen this
measure for several reasons, it is the best predictor of
future self harm attempts; it is a significant marker of
distress; and we know from previous research that indi-
viduals who score 9 or more on this measure are at
least ten times more likely to kill themselves in the next
year. Lastly in our previous trial we had outcome data
at three months or one year on this scale in 85% of
cases. In the previous ACC trial the proportion scoring
9 or more in both groups at baseline was 50%. Using
this as the main outcome measure with 80% power, a
significance level of 0.05 and a reduction in the propor-
tion scoring above 9 from 50% to 25% after a year will
require 66 people in each group, a total of 132. Allowing
for 15% non completion of the Beck Hopelessness Scale
we will need to recruit 155 people which should be fea-
sible to collect over the fifteen months of recruitment
into this trial. The figure of 155 participants is those
people who have been randomised and consented to be
in the study. We would expect that we would need to
randomise about double this number of people to
achieve this target.
Analysis
Statistical analysis will be by the biostatistics team of the
Auckland Clinical Trials Research Unit (CTRU)
Data from the trial will be entered into an Oracle data-
base at the CTRU and extracted into SAS for analysis.
All statistical analyses will be performed using SAS ver-
sion 9.2 (SAS Institute Inc. Cary NC). All statistical tests
will be two-tailed and a 5% significance level maintained
throughout the analyses. Assessment of baseline com-
parability of the intervention and control group will be
carried out via descriptive analyses for demographic
information, method of self-harm, and previous history
of self-harm. The proportion of people repeating self-
harm in each group will be analysed using chi-squared
test. We plan to analyse people whose index episode is a
first presentation and those whose index is a repeat
separately and together. The number of self-harm re-
presentation episodes for the hospital and self report
outcomes during follow-up will be analysed using nega-
tive binomial regression. Kaplan-Meier curves and Cox
proportional hazards regression modeling will be used
to analyze time to first re-presentation to hospital for
self-harm and time to event for the mortality outcomes.
The change from baseline to 3 months and one year in
each of the repeated continuous outcomes will be ana-
lysed using mixed model regression. If baseline charac-
teristics are found to be substantially different between
the groups we will adjust for these in the regression
modeling. All analyses will be conducted on patients
who are randomised and consented except for the re-
presentation to hospital and time to re-presentation out-
comes which will be an intention to treat analysis that
includes all randomised patients including those that did
not consent.
In addition sensitivity analyses will be conducted using
a CACE analysis [31] where appropriate which takes
into account the fact that after randomisation not every-
o n ei naZ e l e nd e s i g na g r e e st ot a k ep a r ti nt h es t u d y .
This has the effect of diluting any treatment effect and
introducing a possible self selection bias. A CACE analy-
s i si sa na t t e m p tt oc o r r e c tf o rt h i s .T h ea s s u m p t i o n
behind this is that those who consent to the interven-
tion and treatment as usual are similar. We will test this
by comparing the main factors which affect outcomes in
both groups including the proportion of people present-
ing for the first time, gender and age.
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We aim to collect the following data from all patients in
the trial at three months and one year after the date of
their index attempt. The data will be collected by a
research assistant by telephone interview with the
patients, by examination of routinely collected health
data and liaison with the finance departments of the
relevant health care providers.
Costs to patients
￿ Time off work
￿ Distance travelled for treatment for all disorders
￿ Time taken for treatment
￿ Costs for attending general practice - travel, pay-
ment to general practice, time off work
￿ Costs of family to attend treatment or provide sup-
port for the patient (for example taking time off
work to be with the patient)
￿ Cost of medication
￿ Benefits claimed
Costs to health care provider
￿ Staff salaries for providing treatment including the
problem solving therapy (therapist and in-patient
treatment)
￿ Length of stay in hospital
￿ Cost of treatments - for example care in intensive
care or burns unit, cost of medication
￿ Overheads
Analysis All analyses will be carried out on an inten-
tion-to-treat basis for total costs over three months and
one year. We will perform multiple regression to adjust
for baseline characteristics including age, sex, number of
previous attempts and Beck Hopelessness Score. We
intend to perform an incremental analysis of costs and
consequences using the primary outcome measure as
the number of repetitions averted. From this we will
produce cost-effectiveness acceptability curves for the
intervention.
We also intend to perform a sensitivity analysis to test
how the costs and consequences of self-harm change
within a range of costs for the different economic
inputs. We anticipate that the model will be most sensi-
tive to changes in the costs of in-patient medical care.
We will also test the sensitivity of the results to produc-
tivity losses and costs of mental health treatment.
Termination of the study
Termination will be considered if there is 10% absolute
greater number of adverse events (re-presentations to
hospital for self harm) in the treatment group than in
the usual care group at three months. Unblinded ana-
lyses to assess excess harm will be conducted at one
year by an independent statistician at CTRU (not the
study statistician). One year was chosen as any shorter
time will mean that there will be few outcomes and any
longer time is close to the end of the intervention at 18
months. For this analysis the Haybittle-Peto stopping
boundary will be used which is based on a three stan-
dard deviation rule corresponding to a two sided test P
= 0.003 stopping rule. This does not affect the power
calculation of the study.
Ethical approval has been received from the New
Zealand, Central Health Ethics Committee.
Discussion
The study, due to report its findings in 2012, tests the
effectiveness of a complex package of interventions in
the management of Maori who present to hospital with
intentional self-harm. It uses a novel design to try and
overcome the problems of previous trials which have
recruited small numbers of unrepresentative people. A
strength of the study is that it is a pragmatic trial which
aims to demonstrate the importance of a comprehensive
approach to culture in assessment and treatment. A
potential limitation is the analysis of the results which is
complex and may underestimate any effect on the sec-
ondary outcomes if a large number of people refuse
their consent in the group randomised to problem sol-
ving therapy as they will effectively cross over to the
treatment as usual group. Another potential issue is col-
lecting a high enough proportion of completed rating
scales at follow up.
Additional material
Additional file 1: EDcard. A copy of the card given to potential
participants informing them that they can refuse to be approached
about the study.
Additional file 2: TIT WDHB. A copy of the postcard given to
consenting participants in the intervention arm.
Additional file 3: TIT3 Month Telephone Interview. The telephone
interview of all consenting participants at three months
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